Adherence to Maintenance-Phase Antidepressant Medication as a Function of Patient Beliefs About Medication

Abstract

PURPOSE This study aimed to identify the demographic, psychiatric, and attitudinal predictors of treatment adherence during the maintenance phase of antidepressant treatment, ie, after symptoms and regimen are stabilized. METHODSWe surveyed 81 primary care patients given maintenance antidepressant medications regarding general adherence, recent missed doses, depression and treatment features, medication beliefs (necessity, concerns, harmfulness, and overprescription), and other variables. Additional data were collected from medical and payer records. RESULTSMedian treatment duration was 75 weeks. Adherence and beliefs were broadly dispersed and unrelated to treatment duration and type, physical functioning, and demographics. Multivariate analysis adjusting for social desirability, depression severity, and treatment duration indicated that an antidepressantspecifi c "necessity-minus-concerns" composite was strongly associated with both adherence outcomes. Specifi cally, adherence was highest when necessity exceeded concerns and lowest when concerns exceeded necessity. We crossed these 2 dimensions to characterize 4 patient attitudes toward antidepressants: skepticism, indifference, ambivalence, and acceptance.CONCLUSIONS Patients given maintenance antidepressants vary widely in adherence. This variation is primarily explained by the balance between their perceptions of need and harmfulness of antidepressant medication, in that adherence is lowest when perceived harm exceeds perceived need, and highest when perceived need exceeds perceived harm. We speculate on ways to tailor adherence strategies to patient beliefs. Subsequent research should determine whether patients' perceptions about medication predict depression outcomes, can be used to improve clinical management, and respond to behavioral intervention.

Potential Impact of Incorporating a Patient-Selected Support Person into mHealth for Depression

“…Because adherence to antidepressant medication improves depression outcomes, 20,21 increased adherence could be one pathway by which extra support may enhance effectiveness. However, symptoms of depression typically require at least 3 to 4 weeks to respond to pharmacotherapy.…”

“…1 Antidepressant medication effectively reduces symptom severity and recurrence risk, but nonadherence is common. 2,3 Although telephone care management is an evidence-based and cost-effective strategy for improving antidepressant medication adherence, 4 its implementation is often not feasible in resource-constrained settings due to high numbers of undertreated patients and limited numbers of trained providers. 5 Mobile health (mHealth) services such as interactive voice response (IVR) telephone calls, smartphone applications, and text messaging may help to address these problems.…”

Integrating Support Persons into Diabetes Telemonitoring to Improve Self-Management and Medication Adherence

“…Finally "psychological distress" is a heterogeneous construct. Insofar as adherence has multiple determinants in distressed medical patients, 33,34 there may be clinically important subgroups within this generalized category who may respond differently to involving a support person in their telemonitoring-based self-management program.…”

Training to Use Motivational Interviewing Techniques for Depression: A Cluster Randomized Trial

“…Change talk around antidepressants, while associated with increased adherence to antidepressant medication in a previous study, 27 may have been driven primarily by underlying patient beliefs or previous experiences with antidepressant medication. 45 MI-trained PCPs may have lacked skill or time to elicit additional change talk around antidepressants but seemed to successfully elicit more change talk targeting physical activity.…”